James R. Shoblock, Ph.D. - Publications

2003 Albany Medical College of Union University 
Neuroscience Biology

14 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Lord B, Aluisio L, Shoblock JR, Neff RA, Varlinskaya EI, Ceusters M, Lovenberg TW, Carruthers N, Bonaventure P, Letavic MA, Deak T, Drinkenburg W, Bhattacharya A. Pharmacology of a novel central nervous system-penetrant P2X7 antagonist JNJ-42253432. The Journal of Pharmacology and Experimental Therapeutics. 351: 628-41. PMID 25271258 DOI: 10.1124/jpet.114.218487  0.88
2014 Winterdahl M, Audrain H, Landau AM, Smith DF, Bonaventure P, Shoblock JR, Carruthers N, Swanson D, Bender D. PET brain imaging of neuropeptide Y2 receptors using N-11C-methyl-JNJ-31020028 in pigs. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 635-9. PMID 24614224 DOI: 10.2967/jnumed.113.125351  0.88
2013 Bhattacharya A, Wang Q, Ao H, Shoblock JR, Lord B, Aluisio L, Fraser I, Nepomuceno D, Neff RA, Welty N, Lovenberg TW, Bonaventure P, Wickenden AD, Letavic MA. Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567. British Journal of Pharmacology. 170: 624-40. PMID 23889535 DOI: 10.1111/bph.12314  0.88
2011 Shoblock JR, Welty N, Aluisio L, Fraser I, Motley ST, Morton K, Palmer J, Bonaventure P, Carruthers NI, Lovenberg TW, Boggs J, Galici R. Selective blockade of the orexin-2 receptor attenuates ethanol self-administration, place preference, and reinstatement. Psychopharmacology. 215: 191-203. PMID 21181123 DOI: 10.1007/s00213-010-2127-x  0.88
2011 Galici R, Rezvani AH, Aluisio L, Lord B, Levin ED, Fraser I, Boggs J, Welty N, Shoblock JR, Motley ST, Letavic MA, Carruthers NI, Dugovic C, Lovenberg TW, Bonaventure P. JNJ-39220675, a novel selective histamine H3 receptor antagonist, reduces the abuse-related effects of alcohol in rats. Psychopharmacology. 214: 829-41. PMID 21086115 DOI: 10.1007/s00213-010-2092-4  0.88
2010 Shoblock JR, Welty N, Nepomuceno D, Lord B, Aluisio L, Fraser I, Motley ST, Sutton SW, Morton K, Galici R, Atack JR, Dvorak L, Swanson DM, Carruthers NI, Dvorak C, et al. In vitro and in vivo characterization of JNJ-31020028 (N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide), a selective brain penetrant small molecule antagonist of the neuropeptide Y Y(2) receptor. Psychopharmacology. 208: 265-77. PMID 19953226 DOI: 10.1007/s00213-009-1726-x  0.88
2009 Welty N, Shoblock JR. The effects of thioperamide on extracellular levels of glutamate and GABA in the rat prefrontal cortex. Psychopharmacology. 207: 433-8. PMID 19795107 DOI: 10.1007/s00213-009-1670-9  0.88
2007 Shoblock JR, Maidment NT. Enkephalin release promotes homeostatic increases in constitutively active mu opioid receptors during morphine withdrawal. Neuroscience. 149: 642-9. PMID 17905519 DOI: 10.1016/j.neuroscience.2007.05.011  0.88
2007 Shoblock JR. The pharmacology of Ro 64-6198, a systemically active, nonpeptide NOP receptor (opiate receptor-like 1, ORL-1) agonist with diverse preclinical therapeutic activity. Cns Drug Reviews. 13: 107-36. PMID 17461893 DOI: 10.1111/j.1527-3458.2007.00007.x  0.88
2006 Shoblock JR, Maidment NT. Constitutively active micro opioid receptors mediate the enhanced conditioned aversive effect of naloxone in morphine-dependent mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 171-7. PMID 15956992 DOI: 10.1038/sj.npp.1300782  0.88
2005 Shoblock JR, Wichmann J, Maidment NT. The effect of a systemically active ORL-1 agonist, Ro 64-6198, on the acquisition, expression, extinction, and reinstatement of morphine conditioned place preference. Neuropharmacology. 49: 439-46. PMID 15919100 DOI: 10.1016/j.neuropharm.2005.04.008  0.88
2004 Shoblock JR, Maisonneuve IM, Glick SD. Differential interactions of desipramine with amphetamine and methamphetamine: evidence that amphetamine releases dopamine from noradrenergic neurons in the medial prefrontal cortex. Neurochemical Research. 29: 1437-42. PMID 15202777 DOI: 10.1023/B:NERE.0000026409.76261.f3  0.88
2003 Shoblock JR, Maisonneuve IM, Glick SD. Differences between d-methamphetamine and d-amphetamine in rats: working memory, tolerance, and extinction. Psychopharmacology. 170: 150-6. PMID 12774190 DOI: 10.1007/s00213-003-1522-y  0.88
2003 Shoblock JR, Sullivan EB, Maisonneuve IM, Glick SD. Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats. Psychopharmacology. 165: 359-69. PMID 12491026 DOI: 10.1007/s00213-002-1288-7  0.88
Show low-probability matches.